VTIAFVita 34 International AG

About Vita 34 International AG (VTIAF)

Vita 34 International AG (VTIAF) is a Medical Care Facilities company headquartered in Leipzig, Germany whose shares trade over-the-counter on the Pink tier.

Founded in Leipzig in 1997 as the first private umbilical cord blood bank in Europe, Vita 34 is a full-range supplier of cryo-preservation and provides for the logistics to collect the blood, the preparation and the storage of stem cells from umbilical cord blood and tissue. Stem cells are a valuable source material for medical cell therapies. They are kept alive at temperatures of around minus 180 degrees Celsius to be able to apply them within the scope of medical treatment, when needed. More than 215.000 customers from Germany and 20 other countries already have opened stem cell deposits with Vita 34, thus providing for the health of their children.

VTIAF key facts

Ticker symbol

VTIAF

Market tier

Pink

Sector

Healthcare

Industry

Medical Care Facilities

Headquarters

Leipzig, Germany

Estimated market cap

$18.74M (as of May 14, 2025)

Shares outstanding

4,145,959

Reporting standard

International Reporting: Frankfurt Stock Exchange

Audit status

Audited

Fiscal year end

12/31

Explore more: Medical Care Facilities stocks · Healthcare sector · Pink stocks · OTC stocks starting with V